NCT04186351 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Beck A, Scott J, Williams P, Robertson B, Jackson D, Gade G, Cowan P
A randomized trial of group outpatient visits for chronically ill older HMO members: the Cooperative Health Care Clinic. J Am Geriatr Soc. 1997 May;45(5):543-9.
Doig GS, Simpson F
Randomization and allocation concealment: a practical guide for researchers. J Crit Care. 2005 Jun;20(2):187-91; discussion 191-3.
Mizrahi T, Abramson JS
Collaboration between social workers and physicians: perspectives on a shared case. Soc Work Health Care. 2000;31(3):1-24.
Sommers LS, Marton KI, Barbaccia JC, Randolph J
Physician, nurse, and social worker collaboration in primary care for chronically ill seniors. Arch Intern Med. 2000 Jun 26;160(12):1825-33.

Efficacy of Providing an Automated Notification Service, the "Encounter Notification Service" Via the eHRSS for Home-based Care and Services Provided by Community Healthcare Providers for the Elderly: A 12-month Randomized Controlled Trial

Details for clinical trial NCT04186351

Clinical trial NCT04186351 - References